Skip to main navigation Skip to search Skip to main content

“The Most High-Risk People Are Given the Most High-Risk Drugs in the Most High-Risk Way”: Experiences of Treating Problematic Over-the-Counter and Prescription-Only Medication Use in Substance Misuse Services

Research output: Contribution to journalArticlepeer-review

5 Downloads (Pure)

Abstract

Misuse of over-the-counter (OTC) and prescription-only medicines (POMs) is increasingly recognised as a public health and medicine-safety concern. Although specialist substance misuse services (SMS) increasingly support people affected by OTC/POM misuse, little is known about how SMS staff perceive the characteristics, challenges, and treatment needs of this population. This study explored the experiences of SMS staff to address this evidence gap and inform pharmacy practice and service development. Confidential semi-structured interviews were conducted with staff across five community adult English SMS. Audio recordings were transcribed verbatim and analysed thematically using NVivo®. Twenty interviews with varied professionals achieved data saturation. Three overarching themes emerged: (1) characteristics of OTC/POM misuse; (2) staff-perceived patterns among people who misuse OTC/POM; and (3) negative experiences and concerns. Dependence on orally administered opioids (particularly codeine-containing products), benzodiazepines and gabapentinoids predominated. Polypharmacy including illicit substance use was also reported. Withdrawal symptoms frequently perpetuated misuse, and abrupt supply cessation created additional risks. Routine enquiry about OTC/POM misuse and provision of tailored harm-reduction interventions are essential. The findings suggest that pharmacists may have an important role in early identification of problematic OTC/POM use, harm-reduction interventions, medicine review and facilitating referral into appropriate treatment pathways. Further research should examine whether dedicated OTC/POM pathways are required and explore differences in demographic and treatment needs across medicine types.
Original languageEnglish
Article number94
Number of pages12
JournalPharmacy
Volume14
Issue number4
Early online date27 Jun 2026
DOIs
Publication statusPublished - 1 Jul 2026

Bibliographical note

Copyright © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.

Data Access Statement

The raw data supporting the conclusions of this article will be made available by the authors upon request.

Funding

This work was supported by the College of Mental Health Pharmacy and Pharmacy Research UK [grant number: PRUK_CMHP-2019-2-RG to RG]. The views expressed in this report are those of the authors and not necessarily those of the CMHP or PRUK.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of '“The Most High-Risk People Are Given the Most High-Risk Drugs in the Most High-Risk Way”: Experiences of Treating Problematic Over-the-Counter and Prescription-Only Medication Use in Substance Misuse Services'. Together they form a unique fingerprint.

Cite this